Daily news email for January 06, 2012 | Click here for updated news
Clinical Trials - Business Wire Research and Markets: Hepatitis B Global Clinical Trials Review, H2, 2011
Research and Markets: Growth Hormone Deficiency Global Clinical Trials Review, H2 2011
Research and Markets: Bronchitis Global Clinical Trials Review, H2, 2011
Research and Markets: Peptic Ulcers Global Clinical Trials Review, H2, 2011
Research and Markets: Generalized Seizures Global Clinical Trials Review, Q1, 2011
|
Clinical Trials - PR Newswire Scottsdale Man is State's 1st to Get New TAVR Heart Valve
Cancer Researcher at Duquesne University Develops Nontoxic Compounds
Novel Brain Tumor Vaccine Acts Like Bloodhound to Locate Cancer Cells
OrbusNeich's Genous Stent Achieves Good, Comparable Clinical Outcomes in Patients Discontinuing Dual Antiplatelet Therapy at 30 Days and at Six Months
One in Six Pregnant Women Tested Are Positive for Hypothyroidism
|
CNN Top Stories Chaz Bono ready to date again
Report: Bomber kills 26 in Syrian capital
Deported teen on way back to U.S.
U.S. Navy rescues Iranian sailors
Joran van der Sloot's Peru trial delayed
|
Sports News - ESPN Hokies' 1,700-yard rusher Wilson to enter draft
Report: All-SEC RB Dyer released by Auburn
Michigan receiver Stonum gets 10-day jail term
RB Sanders to choose Stanford or Oklahoma St.
Bama lands five-star recruit Collins at UA Game
|
Xconomy Life Sciences Alnylam, Aveo, Biogen, & More Boston Life Sciences Newsmakers
Langer, Farokhzad Start New Combo Drug Company, Blend Therapeutics
Civitas Charts Positive Data on Inhaled Parkinson's Drug
Gene Security Network, Now Natera, Adds $20M For Prenatal Tests
San Diego Life Sciences Roundup: Isis, Elevation, Proacta, and More
|
Yahoo Biotech News EU to set new biosimilar drug rules by mid-year
(Reuters)
Connecticut governor seals deal for $1 billion genome lab
(Reuters)
Connecticut seals deal for $1 billion genome lab
(Reuters)
Correction: Stem cell research on donor eggs often not disclosed
(Reuters)
Three arrested for peddling miracle stem cell cure
(Reuters)
|